Suchergebnisse

Abstract
The BEI® committee developed BEIs to equip Occupational and Environmental Health and Safety professionals to effectively integrate biomonitoring into exposure assessment programs. Biological monitoring is the measure of an exposure biomarker in breath, urine, or blood samples, and reflects total chemical uptake. Most BEI® are derived from TLV–TWA, aligning BEI determinant concentration with absorbed amounts at TLV–TWA airborne exposure. Certain BEI® (e.g., lead, CO) prevent adverse health effects directly, while others use population-based values (POPs), especially valuable for carcinogens under ALARA principles. Before setting up a biological monitoring program, why, who, and what to sample need to be determined. The BEI® documentation details how, when, and where to sample, along with transport, storage, analysis, and reporting. The when and why of biological monitoring hinge on diverse occupational exposure routes, recognizing skin absorption and non-occupational factors. Biological monitoring complements air sampling by including all routes of exposure (inhalation, skin absorption, and non-occupational exposures) and in most cases, reflect work-related factors, often adjustable to reduce exposure or implement workplace changes. The ultimate goal is to prevent adverse health effects, ensuring a safe workplace for all.

Abstract

Objectives
Bisphenol A (BPA) is the most used colour developer in thermal paper for cashiers receipts, labels, and tickets. BPA can migrate onto the skin and be absorbed when handling these papers. BPA is a known endocrine disruptor and is therefore being replaced in thermal paper by some alternatives such as Bisphenol S (BPS), D-8, and Pergafast 201® (PF201). To our knowledge, no studies have characterized skin permeation of these BPA alternatives.


Methods
We measured/characterized skin absorption for BPA, BPS, D-8, and PF201 through ex vivo human skin using flow-through diffusion cells according to OECD guideline 428. Skin samples were 7–12 per test substance from three different skin donors. Skin metabolism was studied for BPA. Dermal absorption was expressed as the amount of the BPA alternatives in the receptor fluid over applied dose in percent (%).


Results
The absorbed dose after 24 h of exposure was 25% for BPA, 17% for D-8, 0.4% for BPS, and <LLOQ for PF201. The amount of BPA-glucuronide in the receptor fluid after 24 h was under the limit of quantification (LLOQ = 0.2 µg l−1). Despite the 10-fold lower concentration of the aq solution applied on the skin, D-8's permeation rate JMAX was 5-fold higher than the one for BPS (0.032 versus 0.006 µg cm−2 h−1). Neither D-8 nor BPS permeated readily through the skin (tlag = 3.9 h for D-8, 6.4 h for BPS). None of PF201's skin permeation kinetic parameters could be determined because this BPA analogue was not quantifiable in the receptor fluid in our test conditions.


Conclusions
Skin absorption was in decreasing order: BPA > D-8 >> BPS > PF201. These results are in agreement with their log Kow and molecular weights. We provided here the necessary data to estimate the extent of skin absorption of BPA analogues, which is a necessary step in risk assessment, and ultimately evaluate public health risks posed by D-8, BPS, and PF201.

We evaluated cancer incidence in a cohort of polychlorinated biphenyl (PCB) exposed workers. Incident cancers, identified using state registries, were compared to those in a national population using standardized incidence ratios. Trends in prostate cancer incidence with cumulative PCB exposure were evaluated using standardized rate ratios and Cox regression models. For selected sites, cumulative PCB exposure was compared between aggressive (fatal/distant stage) and localized/regional cancers. We identified 3,371 invasive first primary cancer diagnoses among 21,317 eligible workers through 2007. Overall relative incidence was reduced. Elevations were only observed for respiratory cancers and among women, urinary organ cancers. Among men, prostate cancer incidence was reduced and not associated with cumulative PCB exposure although median exposures were significantly higher for aggressive compared to localized/regional prostate cancers. Previously observed associations between cumulative PCB exposure and prostate cancer mortality were not confirmed in this analysis; prostate cancer stage at diagnosis may explain the discrepancy. Am. J. Ind. Med. 60:198-207, 2017. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Phthalates are suspected to be endocrine disruptors. Di(2-ethylhexyl) phthalate (DEHP) is assumed to have low dermal absorption; however, previous in vitro skin permeation studies have shown large permeation differences. Our aims were to determine DEHP permeation parameters and assess extent of skin DEHP metabolism among workers highly exposed to these lipophilic, low volatile substances. Surgically removed skin from patients undergoing abdominoplasty was immediately dermatomed (800 μm) and mounted on flow-through diffusion cells (1.77 cm(2)) operating at 32°C with cell culture media (aqueous solution) as the reservoir liquid. The cells were dosed either with neat DEHP or emulsified in aqueous solution (166 μg/ml). Samples were analysed by HPLC-MS/MS. DEHP permeated human viable skin only as the metabolite MEHP (100%) after 8h of exposure. Human skin was able to further oxidize MEHP to 5-oxo-MEHP. Neat DEHP applied to the skin hardly permeated skin while the aqueous solution readily permeated skin measured in both cases as concentration of MEHP in the receptor liquid. DEHP pass through human skin, detected as MEHP only when emulsified in aqueous solution, and to a far lesser degree when applied neat to the skin. Using results from older in vitro skin permeation studies with non-viable skin may underestimate skin exposures. Our results are in overall agreement with newer phthalate skin permeation studies.

Abstract
Hydrogen peroxide (H2O2) is a strong oxidizing agent often used in hair coloring and as a component in disinfecting and bleaching processes. Exposures to H2O2 generate reactive oxygen species (ROS) that can cause significant airway irritation and inflammation. Even though workers have reported symptoms associated with sensitivity and irritation from acute exposures below the H2O2 occupational exposure levels (OELs), a lack of sensitive analytical methods for measuring airborne concentrations currently prevents evaluating low or peak H2O2 exposures. To fill these gaps, we propose two different sensitive approaches: (i) luminol chemiluminescence (CL) to specifically measure H2O2; and (ii) photonic sensor method based on the ferrous-xylenol orange assay to evaluate total oxidative potential (OP), a measure of ROS in sampled air. We chose two exposure scenarios: hairdressers preparing and applying hair color to clients (both in simulated and field environments) and workers operating disinfecting cycles at a bottling company. Hair coloring took about 1 h for each client, and the application of the coloring product generated the highest H2O2 concentrations. OP values were highly correlated with H2O2 concentrations (CL measurement) and allowed peak measurements as low as 6 µg m-3 of H2O2 concentrations. The bottling company used a disinfectant containing H2O2, acetic acid and peracetic acid (PAA) in an enclosed process. The photonic sensor was immediately saturated. The CL results showed that the process operator had the highest exposures during a 15-min cycle. There is still a need to develop these direct reading methods for operating in the field, but we believe that in the future an OEL for OP could protect workers from developing airway irritation and inflammation by reducing exposures to oxidizing chemicals.

Abstract
Occupational biomonitoring plays a pivotal role in the assessment and management of chemical workplace exposures. It provides a direct measure of workers' internal dose of chemicals, integrating all sources and routes of exposure. Biomonitoring can bridge the gap between potential exposure scenarios and real-world implications for worker health. Nevertheless, the practical effectiveness of biomonitoring programs relies on the assurance of data quality, comparability, and practical application of the findings to improve occupational health standards.
The ISES Europe Human Biomonitoring working group was established in 2018 with the ambition to promote the generation of high-quality biomonitoring data and its use in occupational settings. Our group made notable progress, especially in establishing standardized Minimum Information Requirements (MIRs). MIRs are sets of guideline specifications that define the structure of minimum metadata attributes in terms of semantics, syntax, findability, and reusability of biomonitoring datasets. MIRs will help in standardising biomonitoring records. It is a complementary approach to the already established personalised medical biomonitoring of occupational medicine.
MIRs will not only improve the consistency and reliability of biomonitoring studies but also help foster a culture of safety and sustainability. By integrating advances in exposure science, including New Approach Methodologies and exposure modelling, into the biomonitoring framework, we can achieve a more robust understanding of occupational exposures. This will ultimately contribute to the refinement and application of Occupational Exposure Limits and Occupational Biomonitoring levels, the design of safer chemicals, and the implementation of effective risk management strategies, thereby safeguarding worker health.

Abstract
We aimed at analyzing dose-response relationship between occupational exposure to a mixture of nanomaterials (NMs) and effect biomarkers measured according to the NanoExplore protocol in exhaled breath condensate (EBC, local pulmonary level)) and urine (systemic level) of 141 workers. Two exposure metrics: particle number concentration (PNC) and lung deposited surface area (LDSA) were monitored using DiSCMini for 2-4 8h-workshifts. Biological samples were collected twice, before and after exposure monitoring. We assumed that current or short-term exposure to NMs is associated in a linear dose-response manner to the effect biomarker concentration. We analyzed each biomarker separately, using the multilevel mixed-effects interval regression models to properly manage the biomarker concentrations the LOD or in the interval between the LOD and the limit of quantification. We used directed acyclic graphs to identify all potential confounders: age, smoking status, medication status, and study center. Center and the participant's ID were modeled as random effect variables. For IL-10, IL-1β and TNF-α in EBC we observed consistent positive dose-response relationships with both PNC and LDSA. For urinary Total Antioxidant Power the relationship was consistently negative. For MDA, KL-6, hs-CRP or NOTyr in EBC and urinary MDA and 8-Isoprostane, no relationship was found. These results suggest an activation of the innate immune response rather than oxidative stress as the main effect of the mixture of NM investigated. This study offers new insights into the dose-response relationship between exposure to NMs and possible indicators of early and long-term biological alterations in the cohort of recruited workers.